The Tie2 antagonist rebastinib reduces ovarian cancer growth in a syngeneic murine model

Related articles

1. Anti-TNFR2 Antibody and HMGN1 Combined with TIL Cell Therapy Inhibits Colorectal Cancer Progression by Enhancing Immune Response

   This article has 13 authors:

   1. Hang Lv
   2. Yujie Nie
   3. Huan Gui
   4. Haohua Yuan
   5. Qianyu Jing
   6. Shuanghui Chen
   7. Linzhao Li
   8. Quan Wan
   9. Liming Zhao
   10. Shengwen Zhou
   11. Shuyi Wang
   12. Jia Song
   13. Yingjie Nie

2. CAMKKβ supports growth and viability of epithelial ovarian cancer in vitro and in vivo

   This article has 6 authors:

   1. Matthew J. Borrelli
   2. Adrian Buensuceso
   3. Yudith Ramos-Valdes
   4. Tiffany P.A. Johnston
   5. Jacob Haagsma
   6. Trevor G. Shepherd

3. Inhibiting B-cell-mediated Immunosuppression to Enhance the Immunotherapy Efficacy in Hepatocellular Carcinoma

   This article has 14 authors:

   1. Dan Duda
   2. Xin Liu
   3. Zelong Liu
   4. Tatsuya Kobayashi
   5. Pin-Ji Lei
   6. Yue Shi
   7. Dandan Yuan
   8. Jianguo Wang
   9. Min Li
   10. Aya Matsui
   11. Kassiana Mafra
   12. Peigen Huang
   13. Ming Kuang
   14. Lloyd Bod